• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

iShares Nasdaq Biotechnology ETF

+ Add to Watchlist

IBB:US

222.1600 USD 0.5690 0.26%

As of 20:10:00 ET on 04/17/2014.

Snapshot for iShares Nasdaq Biotechnology ETF (IBB)

Open: 221.3900 High - Low: 226.3900 - 220.4400 Primary Exchange: NASDAQ GM
Volume: 2,970,974 52-Week Range: 164.1400 - 275.4000 Beta vs XNBI: 1.0048

ETF Chart for IBB

No chart data available.
  • IBB:US 222.1600
  • 1D
  • 1M
  • 1Y
222.7290
Interactive IBB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for IBB

iShares Nasdaq Biotechnology ETF is an exchange-traded fund incorporated in the USA. The Fund's objective seeks investment results that correspond to the performance of the Nasdaq Biotechnology Index. The Fund will concentrate its investments in companies primarily engaged in using biomedical research for the discovery or development of new treatments or cures for human disease.

Inception Date: 2001-02-09 Telephone: 1-415-670-2000
Managers: GREG SAVAGE
Web Site: www.ishares.com

Fundamentals for IBB

NAV (on 2014-04-17) 222.1400
Assets (M) (on 2014-04-17) 4,631.5390
Shares out (M) 20.85
Market Cap (M) 4,632.04
% Premium 0.01
Average 52-Week % Premium -0.0005
Fund Leveraged N

Dividends for IBB

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net -
Dividend Yield (ttm) 0.03%

Performance for IBB

1-Month -13.04% 1-Year +32.99%
3-Month -10.21% 3-Year +28.54%
Year To Date -2.16% 5-Year +28.09%
Expense Ratio 0.48

Top Fund Holdings for IBB

Filing Date: 04/17/2014
Name Position Value % of Total
Amgen Inc 3,598,114 415,438,242 8.865%
Celgene Corp 2,775,987 392,829,920 8.383%
Biogen Idec Inc 1,309,863 380,567,596 8.121%
Gilead Sciences Inc 5,390,015 377,301,050 8.052%
Alexion Pharmaceuticals Inc 2,220,258 332,594,648 7.098%
Regeneron Pharmaceuticals Inc 671,064 199,131,531 4.249%
Mylan Inc/PA 4,015,282 188,397,031 4.020%
Vertex Pharmaceuticals Inc 2,759,499 177,077,051 3.779%
Illumina Inc 1,301,121 176,236,839 3.761%
BioMarin Pharmaceutical Inc 1,725,943 105,092,669 2.243%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil